SEMABIZ launches global biomarker and pulse‑lavage market forecast reports

SEMABIZ, the Japanese distributor for MarketsandMarkets and Grand View Research, announced the sale of two new market‑research reports. On 24 July 2026 the firm began offering the “Biomarkers Market – Global Forecast to 2031”, projecting growth from US$67.95 billion in 2026 to US$112.1 billion by 2031 (CAGR 10.5%). The report cites expanding AI‑driven digital pathology, precision‑medicine adoption and companion‑diagnostic uptake as key drivers.

A day earlier, on 23 July 2026, SEMABIZ released the “Pulse Lavage Market (2026‑2033)” study, forecasting the market to rise from US$55.98 million in 2025 to US$104.37 million by 2033 (CAGR 8.2%). North America, led by the United States, accounts for roughly 40 % of 2025 revenue. Growth is attributed to increasing orthopedic, trauma and cardiovascular surgeries, higher demand for infection‑control solutions, and advances in disposable and battery‑powered lavage devices.

Both reports include detailed segment analyses, competitive landscape reviews and forecasts for regional markets, aiming to aid manufacturers, investors and health‑care providers in strategic planning.